ADAMTS-13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF-A2 domain as substrate.
about
Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditionsPlatelet adhesion involves a novel interaction between vimentin and von Willebrand factor under high shear stressAttack of the acronyms: TTP, VWF, ADAMTS-13 and SELDI-TOF-MS.A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF)-mass spectrometry.Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse.The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency.Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.A rapid enzyme-linked assay for ADAMTS-13.ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpuraADAMTS13 activity and antigen during therapy and follow-up of patients with idiopathic thrombotic thrombocytopenic purpura: correlation with clinical outcomeForce-induced cleavage of single VWFA1A2A3 tridomains by ADAMTS-13.Destabilization of the A1 domain in von Willebrand factor dissociates the A1A2A3 tri-domain and provokes spontaneous binding to glycoprotein Ibalpha and platelet activation under shear stressN-terminal flanking region of A1 domain in von Willebrand factor stabilizes structure of A1A2A3 complex and modulates platelet activation under shear stress.Measurement of ADAMTS13.Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor.Platelet-derived VWF-cleaving metalloprotease ADAMTS-13.Thrombotic thrombocytopenic purpura
P2860
Q28267403-0D89451D-8F0D-4778-A60A-1CF22A4EC05DQ30577008-A11A1A83-B76E-46CB-A997-538166307177Q33231921-6588C9C5-AC20-4267-BC06-EFCB6C66EA91Q33231922-2738DC5E-9E56-4659-8736-0AB4F45D5C38Q33327295-CDF3715E-E8D3-4D6F-83DB-F047DF050D67Q33366935-E3CA0BB3-1119-49EE-9D7F-6A3548FA45FFQ33369765-1831E65F-06EF-4C2E-B030-EAAA31BC15FBQ33369893-E7BC8BC7-BEBF-433B-BA96-B104255BFF94Q33373698-70911406-F4B5-4308-BB6A-11C2A323D964Q33395460-AB366740-2A93-4AF9-AB06-6F6DC047A44CQ33597546-F57900B9-1844-4A30-9719-E5CE51FD50BCQ34003816-D7A6BDDD-7BFE-453A-A329-C24DE41EADA1Q35922561-522E5E3A-4E56-41A9-BFBB-AC36B730D8AAQ36161436-AFB82D57-8C42-4130-A165-A9508AF503CDQ42013734-A1660F34-BD97-4858-8FCD-61536C9F2AD7Q46714550-BD972AC9-03F7-46A1-AE11-8CCC8743B42FQ57591162-EDACD989-61ED-4732-80B7-2B9E3788E23D
P2860
ADAMTS-13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF-A2 domain as substrate.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
ADAMTS-13 activity in plasma i ...... nt VWF-A2 domain as substrate.
@en
ADAMTS-13 activity in plasma i ...... nt VWF-A2 domain as substrate.
@nl
type
label
ADAMTS-13 activity in plasma i ...... nt VWF-A2 domain as substrate.
@en
ADAMTS-13 activity in plasma i ...... nt VWF-A2 domain as substrate.
@nl
prefLabel
ADAMTS-13 activity in plasma i ...... nt VWF-A2 domain as substrate.
@en
ADAMTS-13 activity in plasma i ...... nt VWF-A2 domain as substrate.
@nl
P2093
P2860
P1476
ADAMTS-13 activity in plasma i ...... nt VWF-A2 domain as substrate.
@en
P2093
P2860
P304
P356
10.1111/J.1538-7836.2004.00601.X
P577
2004-03-01T00:00:00Z